CClinicalTrials.gg
CompletedNCT07200700Updated Oct 1, 2025

Inter-rater Reliability of the GNRB Arthrometer

An interventional study of Knee laxity arthrometer in Anterior Cruciate Ligament Reconstruction, sponsored by Vastra Gotaland Region. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by Vastra Gotaland Region · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 5 years after the study started (first participant enrolled Aug 2020, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Although clinical examination is commonly used to diagnose an anterior cruciate ligament (ACL) injury, the method is subjective. For many years, the arthrometer KT1000 has been used to verify clinical results, mostly due to its simplicity. While the KT1000 is no longer available for purchase, other arthrometers have been introduced, one being the Genoroub (GNRB). The latter has several automatic steps, has been marketed to have a higher reproducibility, and able to detect partial tears.

While the KT1000 and GNRB have previously been compared in several studies, it's mostly been compared in healthy subjects. The current study aim to analyse the results in a clinical environment on injured objects and compare the results both before and after ACL reconstruction. The main hypothesis was that the GNRB offers high inter-rater reliability between two examinors and can replace the KT1000 in the everyday clinical setting.

Methods Consecutively, 20 patients > 18 years of age, 12 men and 8 women, with an ACL injury scheduled for surgical reconstruction, were included. All patients were screened between August 2020-2021 at the NU Hospital Group in Trollhattan, Sweden. To be eligible, the patients had to present with a first time ACL injury verified by clinical examination with or without an magnetic resonance imaging, a healthy contralateral knee and to not have sustained multi-ligament injuries to the knee. Minor collateral ligament injuries and meniscal and cartilage injuries were included.

All patients received both spoken and written information before signing an informed consent. The study was approved by the Swedish ethical committee.

All patients were examined both pre- and postoperatively, in accordance with local standard protocol, including range of motion, knee laxity measurements (manual Lachman test, pivot shift test) The participants were examined starting with the healthy/uninjured knee. Who of the two examinors started the testing was randomly decided, however alternated at the follow-up. Clinical examination and KT1000 testing were only performed by examiner 2, given the need for experience with the KT1000 for accurate results.

Statistically, a side-to-side difference (SSD) of 3 mm was set to indicate ACL injury according to general concensus. For the dichotomous values, an SSD of ≥3 mm was considered a yes to ACL injury and \<3mm a no, respectively, for both the GNRB and the KT1000.

A power analysis was performed estimating a difference of 1 mm between examiners with an SD of 1 mm, resulting in 17 patients needed to reach a power of 80% with a significance level of 0.05.

As for the inter-rater reliability, the intra-correlation coefficient (ICC) was calculated and considered poor (\<0.5), moderate (0.5-0.75), good (0.75-0.9) or excellent (>0.9).

02

Conditions studied

  • Anterior Cruciate Ligament Reconstruction

Keywords

  • Anterior cruciate ligament reconstruction, arthrometers, GNRB, KT1000, knee laxity
03

In context

Lead sponsor

Vastra Gotaland Region is the lead sponsor of 267 studies on the registry; 107 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

-

Exclusion criteria

Exclusion Criteria:

Patients under 18 years of age, and those having had previous surgery to any knee, posterior cruciate ligament (PCL) injury or more severe concomitant injuries to the meniscus and collateral ligaments

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Other
    GNRB arthrometer

    Reliability testing GNRB arthrometer between two examinors

    Diagnostic Test: Knee laxity arthrometer

Interventions

  • Diagnostic testKnee laxity arthrometer

    Inter-reliability analysis of the GNRB arthrometer between two examinors compared to standard KT 1000 arthrometer

06

What researchers measure

Primary outcomes

  1. Identifying anterior knee translation in patients with anterior cruciate ligament injury before and after reconstruction compared to the contralateral non-injured knee

    Measuring anterior knee translation in both injured and non injured knee before and after reconstruction using two different devices; GNRB and KT 1000 arthrometer

    Time frame: Primary measurement pre operative, secondary measurement 6-12 months after reconstruction

07

Study locations

1 site
  • NU Hospital Group
    Trollhättan, Europe 46185, Sweden
08

References and documents

Individual participant data

Plan to share: Yes — As the study is a part of future thesis data will be available in this publication

Supporting information: Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07200700
Lead sponsor
Vastra Gotaland Region
Responsible party
Ninni Sernert (Professor, Research director, Vastra Gotaland Region) — Principal investigator
First posted
Oct 1, 2025
Start date
Aug 24, 2020
Primary completion
Dec 20, 2022
Completion
Dec 20, 2022
Last update
Oct 1, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion